PEG-MGF
Preclinical — Animal / cell-model data onlyWhat it is
A pegylated mechano-growth-factor variant studied for muscle-repair signalling, largely preclinical.
PEG-MGF is a pegylated mechano-growth-factor variant studied for muscle-repair signalling, largely in preclinical work.
Research context
Studied in relation to:
- Muscle-repair research
Points in its favour in the literature:
- Targets local repair pathways
Caveats and unknowns:
- Human evidence minimal
- Unlicensed for human use
- Prohibited in sport
Handling & reference data
Route in published researchSubcutaneous injection is the route most commonly described in the research literature.
Published clinical / research context (not instructions)Reported research ~200–400 mcg, about twice weekly.
Storage (lyophilised)Lyophilised (freeze-dried) powder: refrigerate at 2–8 °C short-term, or freeze at −20 °C or below for long-term storage. Keep sealed and out of light.
Reconstituted solutionOnce reconstituted: keep refrigerated (2–8 °C), protect from light, do not freeze. With bacteriostatic water, commonly used within ~4 weeks; with plain sterile water, within ~24–48 h.
Worked reconstitution example (arithmetic only)e.g. 2 mg vial + 2 mL → 1 mg/mL.
Available research formats
| Strength | SKU |
|---|---|
| 2mg | FMP2 |
Current pricing (THB with USD/GBP conversion) is shown live in the catalogue, which also has a transparent U-100 reconstitution calculator.